KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. (KALV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KALV · as of Jun 8, 2026
Key Statistics
Explore KalVista Pharmaceuticals, Inc. Data
kalv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 84.6%
The KALV analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $28.67, representing +6.38% upside from the current price of $26.95.
Competitors & Peers
kalv competitorsKALV
ADCT
BCYC
FDMT
GOSS
OLMAStock Performance
Full HistoryAbout KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product…
what is kalvista pharmaceuticals, inc. · kalv stock overview · kalvista pharmaceuticals, inc. company profile · who is kalvista pharmaceuticals, inc. ceo · kalv NASDAQ · kalvista pharmaceuticals, inc. headquarters · kalvista pharmaceuticals, inc. business segments
About Stock Overview & Key Data
KalVista Pharmaceuticals, Inc. (KALV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 9, 2015. As of the latest trading session, KALV stock price is $26.95, with a market capitalization of $1.4B. The stock has returned +82.59% over the past 12 months and +66.87% year-to-date.
According to 13 Wall Street analysts, the consensus rating for KalVista Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $28.67. In fiscal year 2025, KalVista Pharmaceuticals, Inc. reported revenue of $73.6M and net income of -$164.3M. For detailed data — including KalVista Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, KalVista Pharmaceuticals, Inc. (KALV) stock price is $26.95. The stock is traded on NASDAQ under the ticker symbol KALV. The 52-week range is $9.83 – $26.98.